418 related articles for article (PubMed ID: 19201877)
1. Absence of mucosal immunity in the human upper respiratory tract to the commensal bacteria Neisseria lactamica but not pathogenic Neisseria meningitidis during the peak age of nasopharyngeal carriage.
Vaughan AT; Gorringe A; Davenport V; Williams NA; Heyderman RS
J Immunol; 2009 Feb; 182(4):2231-40. PubMed ID: 19201877
[TBL] [Abstract][Full Text] [Related]
2. Neisseria lactamica selectively induces mitogenic proliferation of the naive B cell pool via cell surface Ig.
Vaughan AT; Brackenbury LS; Massari P; Davenport V; Gorringe A; Heyderman RS; Williams NA
J Immunol; 2010 Sep; 185(6):3652-60. PubMed ID: 20709949
[TBL] [Abstract][Full Text] [Related]
3. Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.
Evans CM; Pratt CB; Matheson M; Vaughan TE; Findlow J; Borrow R; Gorringe AR; Read RC
Clin Infect Dis; 2011 Jan; 52(1):70-7. PubMed ID: 21148522
[TBL] [Abstract][Full Text] [Related]
4. Regulation of Th-1 T cell-dominated immunity to Neisseria meningitidis within the human mucosa.
Davenport V; Groves E; Hobbs CG; Williams NA; Heyderman RS
Cell Microbiol; 2007 Apr; 9(4):1050-61. PubMed ID: 17166235
[TBL] [Abstract][Full Text] [Related]
5. Can Neisseria lactamica antigens provide an effective vaccine to prevent meningococcal disease?
Gorringe AR
Expert Rev Vaccines; 2005 Jun; 4(3):373-9. PubMed ID: 16026250
[TBL] [Abstract][Full Text] [Related]
6. The use of monoclonal antibodies to Neisseria lactamica in an antigen selection to Neisseria meningitides B vaccine.
De Gaspari EN
Hybridoma (Larchmt); 2008 Oct; 27(5):387-93. PubMed ID: 18803504
[TBL] [Abstract][Full Text] [Related]
7. Neisseria meningitidis, Neisseria lactamica and Moraxella catarrhalis share cross-reactive carbohydrate antigens.
Braun JM; Beuth J; Blackwell CC; Giersen S; Higgins PG; Tzanakaki G; Unverhau H; Weir DM
Vaccine; 2004 Feb; 22(7):898-908. PubMed ID: 15040943
[TBL] [Abstract][Full Text] [Related]
8. Comparison of the inflammatory responses of human meningeal cells following challenge with Neisseria lactamica and with Neisseria meningitidis.
Fowler MI; Yin KY; Humphries HE; Heckels JE; Christodoulides M
Infect Immun; 2006 Nov; 74(11):6467-78. PubMed ID: 16954390
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles of Neisseria lactamica as a potential mucosal adjuvant.
Sardiñas G; Reddin K; Pajon R; Gorringe A
Vaccine; 2006 Jan; 24(2):206-14. PubMed ID: 16115701
[TBL] [Abstract][Full Text] [Related]
10. Immunization with live Neisseria lactamica protects mice against meningococcal challenge and can elicit serum bactericidal antibodies.
Li Y; Zhang Q; Winterbotham M; Mowe E; Gorringe A; Tang CM
Infect Immun; 2006 Nov; 74(11):6348-55. PubMed ID: 16966413
[TBL] [Abstract][Full Text] [Related]
11. Human airway epithelial cell responses to Neisseria lactamica and purified porin via Toll-like receptor 2-dependent signaling.
Liu X; Wetzler LM; Nascimento LO; Massari P
Infect Immun; 2010 Dec; 78(12):5314-23. PubMed ID: 20937766
[TBL] [Abstract][Full Text] [Related]
12. Neisseria lactamica Controlled Human Infection Model.
Dale AP; Gbesemete DF; Read RC; Laver JR
Methods Mol Biol; 2022; 2414():387-404. PubMed ID: 34784048
[TBL] [Abstract][Full Text] [Related]
13. The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.
Gorringe A; Halliwell D; Matheson M; Reddin K; Finney M; Hudson M
Vaccine; 2005 Mar; 23(17-18):2210-3. PubMed ID: 15755597
[TBL] [Abstract][Full Text] [Related]
14. Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.
Vaughan TE; Skipp PJ; O'Connor CD; Hudson MJ; Vipond R; Elmore MJ; Gorringe AR
Vaccine; 2006 Jun; 24(25):5277-93. PubMed ID: 16682101
[TBL] [Abstract][Full Text] [Related]
15. Nasal Inoculation of the Commensal Neisseria lactamica Inhibits Carriage of Neisseria meningitidis by Young Adults: A Controlled Human Infection Study.
Deasy AM; Guccione E; Dale AP; Andrews N; Evans CM; Bennett JS; Bratcher HB; Maiden MC; Gorringe AR; Read RC
Clin Infect Dis; 2015 May; 60(10):1512-20. PubMed ID: 25814628
[TBL] [Abstract][Full Text] [Related]
16. [Factors affecting Neisseria meningitidis and Neisseria lactamica carrier state].
Krízová P; Vlcková J
Epidemiol Mikrobiol Imunol; 1998 Dec; 47(4):131-6. PubMed ID: 9919812
[TBL] [Abstract][Full Text] [Related]
17. Carriage of Neisseria meningitidis and Neisseria lactamica in infants and children.
Gold R; Goldschneider I; Lepow ML; Draper TF; Randolph M
J Infect Dis; 1978 Feb; 137(2):112-21. PubMed ID: 415097
[TBL] [Abstract][Full Text] [Related]
18. Effect of colonisation with Neisseria lactamica on cross-reactive anti-meningococcal B-cell responses: a randomised, controlled, human infection trial.
Dale AP; Theodosiou AA; Gbesemete DF; Guy JM; Jones EF; Hill AR; Ibrahim MM; de Graaf H; Ahmed M; Faust SN; Gorringe AR; Polak ME; Laver JR; Read RC
Lancet Microbe; 2022 Dec; 3(12):e931-e943. PubMed ID: 36462524
[TBL] [Abstract][Full Text] [Related]
19. Genetic diversity and carriage dynamics of Neisseria lactamica in infants.
Bennett JS; Griffiths DT; McCarthy ND; Sleeman KL; Jolley KA; Crook DW; Maiden MC
Infect Immun; 2005 Apr; 73(4):2424-32. PubMed ID: 15784588
[TBL] [Abstract][Full Text] [Related]
20. Rapid characterization of outer-membrane proteins in Neisseria lactamica by SELDI-TOF-MS (surface-enhanced laser desorption ionization-time-of-flight MS) for use in a meningococcal vaccine.
Mukhopadhyay TK; Halliwell D; O'Dwyer C; Shamlou PA; Levy MS; Allison N; Gorringe A; Reddin KM
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):175-82. PubMed ID: 15315478
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
